Download Diapositive 1 - univ

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Public health genomics wikipedia , lookup

MicroRNA wikipedia , lookup

Transposable element wikipedia , lookup

Nutriepigenomics wikipedia , lookup

Epigenetics of diabetes Type 2 wikipedia , lookup

Vectors in gene therapy wikipedia , lookup

Gene expression profiling wikipedia , lookup

Medical genetics wikipedia , lookup

Designer baby wikipedia , lookup

Metagenomics wikipedia , lookup

Long non-coding RNA wikipedia , lookup

History of RNA biology wikipedia , lookup

Gene therapy of the human retina wikipedia , lookup

Gene expression programming wikipedia , lookup

Site-specific recombinase technology wikipedia , lookup

Primary transcript wikipedia , lookup

Non-coding RNA wikipedia , lookup

Artificial gene synthesis wikipedia , lookup

Mir-92 microRNA precursor family wikipedia , lookup

Therapeutic gene modulation wikipedia , lookup

RNA silencing wikipedia , lookup

RNA-Seq wikipedia , lookup

RNA interference wikipedia , lookup

Transcript
Dazl shRNA construct design
Dann C T et al. PNAS 2006;103:11246-11251
©2006 by National Academy of Sciences
Transgene expression and DAZL knockdown
Dann C T et al. PNAS 2006;103:11246-11251
©2006 by National Academy of Sciences
Analysis of Dazl-shRNA phenotype
Dann C T et al. PNAS 2006;103:11246-11251
©2006 by National Academy of Sciences
Reverse genetics in the rat: Advantages to using
in vivo RNAi over traditional knock-out methods
• Because of the small size of the sequences encoding shRNAs, these
sequences can be cloned in lentiviral vectors
• Production of transgenic founders with lentivirus is easy and efficient
• In vivo RNAi allows to generate animals with different degrees of gene
deficiency. An allelic series of hypomorphs is often more informative for
modeling human disease phenotypes
• Conditional in vivo RNAi approach is now feasable in the rat using tissue
specific promoters (RNA polymerase II promoters) driving the expression
of shRNAs (embedded in microRNAs)